Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3878238 | The Journal of Urology | 2008 | 4 Pages |
Abstract
Prostate specific antigen velocity more than 2 ng/ml per year has been linked to a significantly greater risk of prostate cancer specific mortality. Patients who underwent serial screening had a more favorable prostate specific antigen velocity profile at diagnosis, suggesting that screen detected prostate cancer may be more likely to be cured with definitive therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Joshua J. Meeks, C. Shad Thaxton, Stacy Loeb, Kimberly A. Roehl, Brian T. Helfand, William J. Catalona,